Skip to main content
SpringerLink
Log in

Hong Kong Experience

  • Chapter
  • First Online:
Esophageal Squamous Cell Carcinoma

  • 1118 Accesses

Abstract

Esophageal cancer is the sixth most common cancer in the world [1]. There has been a divergence of histological cell type between the East and West. In western countries, adenocarcinoma has increased dramatically in incidence in the past 30 years, closely related to rising prevalence of obesity, gastroesophageal reflux disease, and Barrett’s esophagus. In Asia, esophageal squamous cell carcinoma (ESCC) remains the predominant cell type; more than 80 % of esophageal cancer is squamous cell in origin. There has not been a convincing rise in incidence of true adenocarcinoma of the esophagus (Siewert type I) in Asia. In Hong Kong, ESCC accounts for more than 90 % of all esophageal cancers. In 2010, the Cancer Registry of Hong Kong identified esophageal cancer as the eighth leading cause of cancer deaths. The overall 5-year survival rate was disappointing at around 20 % only [2].

There has been advancement of technology in diagnosis, staging, and treatment of this highly lethal disease in the last few decades. In Hong Kong, more than 70 % of esophageal cancer patients are diagnosed at stage III/IV. Diagnosis at an earlier stage can improve the outcome and prognosis. Accurate staging allows optimal stage-directed therapeutic strategy. Multimodality treatment methods such as neoadjuvant chemotherapy or chemoradiation with surgery have gained popularity and outcomes have improved compared with surgical resection alone. The authors will summarize the treatment strategies and experience at The University of Hong Kong.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

    Article  PubMed  CAS  Google Scholar 

  2. Hospital Authority (2012) Hong Kong Cancer Registry. http://www3.ha.org.hk/cancereg. Accessed 20 Aug 2014

  3. Cheung HC, Siu KF, Wong J (1988) A comparison of flexible and rigid endoscopy in evaluating esophageal cancer patients for surgery. World J Surg 12(1):117–122

    Article  PubMed  CAS  Google Scholar 

  4. Fok M, Cheng SW, Wong J (1992) Endosonography in patient selection for surgical treatment of esophageal carcinoma. World J Surg 16(6):1098–1103, discussion 1103

    Article  PubMed  CAS  Google Scholar 

  5. Choi TK, Siu KF, Lam KH, Wong J (1984) Bronchoscopy and carcinoma of the esophagus I. Findings of bronchoscopy in carcinoma of the esophagus. Am J Surg 147(6):757–759

    Article  PubMed  CAS  Google Scholar 

  6. Choi TK, Siu KF, Lam KH, Wong J (1984) Bronchoscopy and carcinoma of the esophagus II. Carcinoma of the esophagus with tracheobronchial involvement. Am J Surg 147(6):760–762

    Article  PubMed  CAS  Google Scholar 

  7. Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14(10):1479–1490

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lowe VJ, Booya F, Fletcher JG et al (2005) Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7(6):422–430

    Article  PubMed  Google Scholar 

  9. Dittler HJ, Bollschweiler E, Siewert JR (1991) What is the value of endosonography in the preoperative staging of esophageal carcinoma? Dtsch Med Wochenschr 116(15):561–566

    Article  PubMed  CAS  Google Scholar 

  10. Law S, Wong KH, Tong DK, Wong J (2007) Standardized uptake value (SUV) in PET/CT for oesophageal cancer correlates with pathological stage and predicts R-category of resection. Gut 56(suppl 3):A223

    Google Scholar 

  11. Lagarde SM, Maris AK, de Castro SM, Busch OR, Obertop H, van Lanschot JJ (2007) Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 94(12):1521–1526

    Article  PubMed  CAS  Google Scholar 

  12. Law SY, Fok M, Wong J (1994) Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 18(3):339–346

    Article  PubMed  CAS  Google Scholar 

  13. Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kuwano H, Nishimura Y, Ohtsu A et al (2008) Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I edited by the Japan Esophageal Society. Esophagus 5:61–73

    Article  Google Scholar 

  15. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27(30):5062–5067

    Article  PubMed  Google Scholar 

  16. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359(9319):1727–1733

    Article  Google Scholar 

  17. Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19(1):68–74

    Article  PubMed  Google Scholar 

  18. Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326(24):1593–1598

    Article  PubMed  CAS  Google Scholar 

  19. al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15(1):277–284

    PubMed  CAS  Google Scholar 

  20. Cooper JS, Guo MD, Herskovic A, Radiation Therapy Oncology Group et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Jama 281(17):1623–1627

    Article  PubMed  CAS  Google Scholar 

  21. van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084

    Article  PubMed  Google Scholar 

  22. Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113(2):138–147

    PubMed  CAS  Google Scholar 

  23. Chen J, Zhu J, Pan J et al (2010) Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 90(2):435–442

    Article  PubMed  Google Scholar 

  24. Xiao ZF, Yang ZY, Liang J et al (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75(2):331–336

    Article  PubMed  Google Scholar 

  25. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114(2):210–217

    Article  PubMed  CAS  Google Scholar 

  26. Lam KY, Law S, Ma LT, Ong SK, Wong J (1997) Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? Eur J Cancer 33(8):1221–1225

    Article  PubMed  CAS  Google Scholar 

  27. Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17(8):2184–2192

    Article  PubMed  PubMed Central  Google Scholar 

  28. Law S, Kwong DL, Kwok KF et al (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238(3):339–347, discussion 347–338

    PubMed  PubMed Central  Google Scholar 

  29. Tong DK, Law S, Kwong DL, Chan SY, Wong KH (2011) What is the appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer. World J Surg 35(Suppl 1):S172 (0450)

    Google Scholar 

  30. Law S, Kwong DL, Wong KH, Kwok KF, Wong J (2006) The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 10(9):1301–1311

    Article  PubMed  Google Scholar 

  31. Weber WA, Ott K, Becker K et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19(12):3058–3065

    PubMed  CAS  Google Scholar 

  32. Lordick F, Ott K, Krause BJ et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8(9):797–805

    Article  PubMed  Google Scholar 

  33. Ong GB, Lee TC (1960) Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus. Br J Surg 48:193–200

    Article  PubMed  CAS  Google Scholar 

  34. Law SY, Fok M, Wei WI et al (2000) Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg 70(2):418–422

    Article  PubMed  CAS  Google Scholar 

  35. Cense HA, Law S, Wei W et al (2007) Pharyngolaryngoesophagectomy using the thoracoscopic approach. Surg Endosc 21(6):879–884

    Article  PubMed  CAS  Google Scholar 

  36. Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH (2011) Current management of cervical esophageal cancer. World J Surg 35(3):600–607

    Article  PubMed  Google Scholar 

  37. Wei WI, Lam LK, Yuen PW, Wong J (1998) Current status of pharyngolaryngo-esophagectomy and pharyngogastric anastomosis. Head Neck 20(3):240–244

    Article  PubMed  CAS  Google Scholar 

  38. Lam KH, Wong J, Lim ST, Ong GB (1981) Pharyngogastric anastomosis following pharyngolaryngoesophagectomy. Analysis of 157 cases. World J Surg 5(4):509–516

    Article  PubMed  CAS  Google Scholar 

  39. Spiro RH, Bains MS, Shah JP, Strong EW (1991) Gastric transposition for head and neck cancer: a critical update. Am J Surg 162(4):348–352

    Article  PubMed  CAS  Google Scholar 

  40. Le Quesne LP, Ranger D (1966) Pharyngolaryngectomy, with immediate pharyngogastric anastomosis. Br J Surg 53(2):105–109

    Article  PubMed  Google Scholar 

  41. Wei WI, Lam LK, Yuen PW, Kwong D, Chan KW (1998) Mucosal changes of the free jejunal graft in response to radiotherapy. Am J Surg 175(1):44–46

    Article  PubMed  CAS  Google Scholar 

  42. Chan JY, Liu LH, Wei WI (2013) Early prediction of anastomotic leakage after free jejunal flap reconstruction of circumferential pharyngeal defects. J Plast Reconstr Aesthet Surg 66(3):376–381

    Article  PubMed  Google Scholar 

  43. Chu KM, Law SY, Fok M, Wong J (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 174(3):320–324

    Article  PubMed  CAS  Google Scholar 

  44. Law S, Fok M, Chu KM, Wong J (1997) Thoracoscopic esophagectomy for esophageal cancer. Surgery 122(1):8–14

    Article  PubMed  CAS  Google Scholar 

  45. Law S, Wong J (2002) Use of minimally invasive oesophagectomy for cancer of the oesophagus. Lancet Oncol 3(4):215–222

    Article  PubMed  Google Scholar 

  46. Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892

    Article  PubMed  Google Scholar 

  47. Law S (2012) Is minimally invasive preferable to open oesophagectomy? Lancet 379(9829):1856–1858

    Article  PubMed  Google Scholar 

  48. Law S, Arcilla C, Chu KM, Wong J (1998) The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176(3):286–290

    Article  PubMed  CAS  Google Scholar 

  49. Law SY, Fok M, Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83(1):107–111

    Article  PubMed  CAS  Google Scholar 

  50. Tong DK, Kwong DL, Law S, Wong KH, Wong J (2008) Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease. J Gastrointest Surg 12(10):1638–1645, discussion 1645

    Article  PubMed  Google Scholar 

  51. Fok M, Cheng SW, Wong J (1991) Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg 162(5):447–452

    Article  PubMed  CAS  Google Scholar 

  52. Lee YM, Law S, Chu KM, Wong J (2000) Pyloroplasty in gastric replacement of the esophagus after esophagectomy: one-layer or two-layer technique? Dis Esophagus 13(3):203–206

    Article  PubMed  CAS  Google Scholar 

  53. Law S, Cheung MC, Fok M, Chu KM, Wong J (1997) Pyloroplasty and pyloromyotomy in gastric replacement of the esophagus after esophagectomy: a randomized controlled trial. J Am Coll Surg 184(6):630–636

    PubMed  CAS  Google Scholar 

  54. Davis PA, Law S, Wong J (2003) Colonic interposition after esophagectomy for cancer. Arch Surg 138(3):303–308

    Article  PubMed  Google Scholar 

  55. Tong DK, Law S, Chan SY (2012) Operative outcomes of colonic interposition in the treatment of esophageal cancer: a three decades experience. Gastroenterology 142(5):S-1075, Supplement 1

    Google Scholar 

  56. Gawad KA, Hosch SB, Bumann D et al (1999) How important is the route of reconstruction after esophagectomy: a prospective randomized study. Am J Gastroenterol 94(6):1490–1496

    Article  PubMed  CAS  Google Scholar 

  57. Wong AC, Law S, Wong J (2003) Influence of the route of reconstruction on morbidity, mortality and local recurrence after esophagectomy for cancer. Dig Surg 20(3):209–214

    Article  PubMed  Google Scholar 

  58. Tong DK, Law S (2013) Reconstruction after pharyngolaryngectomy and esophagectomy: challenges and outcomes. Jpn Bronco Esophagol Soc 64(2):65–70

    Article  Google Scholar 

  59. Biere SS, Maas KW, Cuesta MA, van der Peet DL (2011) Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg 28(1):29–35

    Article  PubMed  CAS  Google Scholar 

  60. Law S, Fok M, Chu KM, Wong J (1997) Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 226(2):169–173

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  61. Whooley BP, Law S, Alexandrou A, Murthy SC, Wong J (2001) Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer. Am J Surg 181(3):198–203

    Article  PubMed  CAS  Google Scholar 

  62. Lorentz T, Fok M, Wong J (1989) Anastomotic leakage after resection and bypass for esophageal cancer: lessons learned from the past. World J Surg 13(4):472–477

    Article  PubMed  CAS  Google Scholar 

  63. Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J (2003) Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 126(4):1162–1167

    Article  PubMed  Google Scholar 

  64. Tsui SL, Law S, Fok M et al (1997) Postoperative analgesia reduces mortality and morbidity after esophagectomy. Am J Surg 173(6):472–478

    Article  PubMed  CAS  Google Scholar 

  65. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J (2001) Analysis of reduced death and complication rates after esophageal resection. Ann Surg 233(3):338–344

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  66. Whooley BP, Law S, Murthy SC, Alexandrou A, Chu KM, Wong J (2002) The Kirschner operation in unresectable esophageal cancer: current application. Arch Surg 137(11):1228–1232

    Article  PubMed  Google Scholar 

  67. Wong J, Lam KH, Wei WI, Ong GB (1981) Results of the Kirschner operation. World J Surg 5(4):547–552

    Article  PubMed  CAS  Google Scholar 

  68. Tong DK, Law S, Wong KH (2010) The use of self-expanding metallic stents (SEMS) is effective in symptom palliation from recurrent tumor after esophagogastrectomy for cancer. Dis Esophagus 23(8):660–665

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Esophageal and Upper Gastrointestinal Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong

    Daniel Tong MBBS, PhD, MS, FRACS & Simon Law MBBChir, MS, FRCSEd, FACS

Authors
  1. Daniel Tong MBBS, PhD, MS, FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon Law MBBChir, MS, FRCSEd, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Law MBBChir, MS, FRCSEd, FACS .

Editor information

Editors and Affiliations

  1. Department of Surgery, International Goodwill Hospital, Yokohama, Kanagawa, Japan

    Nobutoshi Ando

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Japan

About this chapter

Cite this chapter

Tong, D., Law, S. (2015). Hong Kong Experience. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54977-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54977-2_15

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54976-5

  • Online ISBN: 978-4-431-54977-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation